Affiliation:
1. Department of General, Inorganic and Theoretical Chemistry, Center for Molecular Biosciences Innsbruck (CMBI), University of Innsbruck, 6020 Innsbruck, Austria
Abstract
Camelid heavy-chain antibody variable domains (VHH), nanobodies, are the smallest-known functional antibody fragments with high therapeutic potential. In this study, we investigate a VHH binding to hen egg-white lysozyme (HEL). We structurally and dynamically characterized the conformational diversity of four VHH variants to elucidate the antigen-binding process. For two of these antibodies, not only are the dissociation constants known, but also the experimentally determined crystal structures of the VHH in complex with HEL are available. We performed well-tempered metadynamics simulations in combination with molecular dynamics simulations to capture a broad conformational space and to reconstruct the thermodynamics and kinetics of conformational transitions in the antigen-binding site, the paratope. By kinetically characterizing the loop movements of the paratope, we found that, with an increase in affinity, the state populations shift towards the binding competent conformation. The contacts contributing to antigen binding, and those who contribute to the overall stability, show a clear trend towards less variable but more intense contacts. Additionally, these investigated nanobodies clearly follow the conformational selection paradigm, as the binding competent conformation pre-exists within the structural ensembles without the presence of the antigen.
Funder
Austrian Science Fund
APART-MINT PostDoc fellowship of the Austrian Academy of Sciences
Subject
Molecular Biology,Biochemistry
Reference74 articles.
1. Antibody Repertoire Development in Camelids;Saerens;Dev. Comp. Immunol.,2006
2. Antibody Repertoire Development in Cartilaginous Fish;Dooley;Dev. Comp. Immunol.,2006
3. Camelid Immunoglobulins and Nanobody Technology;Muyldermans;Vet. Immunol. Immunopathol.,2009
4. Flajnik, M.F., Deschacht, N., and Muyldermans, S. (2011). A Case of Convergence: Why Did a Simple Alternative to Canonical Antibodies Arise in Sharks and Camels?. PLoS Biol., 9.
5. Chiu, M.L., Goulet, D.R., Teplyakov, A., and Gilliland, G.L. (2019). Antibody Structure and Function: The Basis for Engineering Therapeutics. Antibodies, 8.